A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia
Clinical trial NCT06238466 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06238466
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-16
- Primary completion
- 2025-12-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.